Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 1951 | 375 | 0.2251 | 0.2433 | 0.1922 | 0.1994 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 914 | 160 | 0.0382 | 0.0434 | 0.1751 | 0.1958 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1560 | 1386 | 0.0249 | 0.0314 | 0.8885 | 0.8595 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1135 | 1078 | 0.0081 | 0.0064 | 0.9498 | 0.9579 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1681 | 1503 | 0.0254 | 0.0314 | 0.8941 | 0.8595 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1196 | 197 | 0.0506 | 0.0492 | 0.1647 | 0.1635 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1093 | 1032 | 0.0087 | 0.0084 | 0.9442 | 0.9531 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1221 | 62 | 0.0587 | 0.0545 | 0.0508 | 0.0467 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1440 | 1382 | 0.0083 | 0.0084 | 0.9597 | 0.9531 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1138 | 197 | 0.0477 | 0.0492 | 0.1731 | 0.1635 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1247 | 1183 | 0.0091 | 0.0097 | 0.9487 | 0.9430 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1115 | 1046 | 0.0099 | 0.0097 | 0.9381 | 0.9430 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1231 | 1160 | 0.0101 | 0.0097 | 0.9423 | 0.9430 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1153 | 176 | 0.0495 | 0.0492 | 0.1526 | 0.1635 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 8666 | 164 | 0.4305 | 0.4180 | 0.0189 | 0.0173 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 7914 | 1171 | 0.9632 | 1.0000 | 0.1480 | 0.1514 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1056 | 45 | 0.0512 | 0.0545 | 0.0426 | 0.0467 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 8309 | 1285 | 1.0034 | 1.0000 | 0.1547 | 0.1514 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 451 | 88 | 0.2780 | 0.2918 | 0.1951 | 0.1993 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 8526 | 1292 | 1.0334 | 1.0000 | 0.1515 | 0.1514 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1292 | 66 | 0.0621 | 0.0577 | 0.0511 | 0.0487 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 2337 | 557 | 0.2543 | 0.2671 | 0.2383 | 0.2394 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 753 | 46 | 0.5415 | 0.7322 | 0.0611 | 0.0524 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1253 | 76 | 0.9015 | 1.0853 | 0.0607 | 0.0619 |